Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BE Berkeley Catalyst DLLSTH3 people · Follows rounds	88🔒	Berkeley	US	Seed–Series A	—	+ Add to CRM
7G 7G BioVentures VXSWPDRD5 people	88🔒	Burlingame	US	—	—	+ Add to CRM
KE Kendall Capital Partners DZJBDRGM7 people	88🔒	Boston	US	Seed–Growth	—	+ Add to CRM
TO Torrey Pines Investment NSCRERMP7 people · Leads rounds	88🔒	San Diego	US	Seed–Series A	—	+ Add to CRM
CO Corner Ventures JPMTDKDK12 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
DE Deviation Capital CBDPJGTM6 people	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
ET ETCapital MRJGDG3 people · Follows rounds	88🔒	Cambridge	GB	Pre-Seed–Series A	$100K – $952.5K	+ Add to CRM
JU Jumpstart Nova MWKCVG3 people · Leads rounds	88🔒	Nashville	US	Seed–Series A	$250K – $4M	+ Add to CRM
MI Militia Hill Ventures JHBJLDS9 people	88🔒	Philadelphia	US	Seed–Series A	—	+ Add to CRM
ON Ono Venture Investment, Inc. SMDNHTKT6 people	88🔒	South San Francisco	US	Seed–Series B	—	+ Add to CRM
CL Claremont Creek Ventures NGRHBWGO5 people	88🔒	Oakland	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
HO Hourglass Venture Partners RELGSRS8 people	88🔒	San Francisco	US	—	—	+ Add to CRM
SU Sugati Ventures RDEGMCEH8 people · Leads rounds	88🔒	San Ramon	US	Seed–Series A	—	+ Add to CRM
7T 7thirty JJMT2 people · Leads rounds	88🔒	Boulder	US	Seed–Series B	$100K – $1M	+ Add to CRM
BL BlueStone Venture Partners MATNCBAM4 people	88🔒	Tucson	US	Seed–Series B	$250K – $1M	+ Add to CRM
LO Louisiana Funds RBJLLML4 people	88🔒	Baton Rouge	US	Pre-Seed–Series A	—	+ Add to CRM
AC Actuate Ventures AWCLJOJW6 people	88🔒	Seattle	US	Pre-Seed–Seed	—	+ Add to CRM
SV SVG Ventures HHJHGYJC9 people · Leads rounds	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
AD Aditum Bio JGJJCKIZ8 people	88🔒	Oakland	US	Series A–Series B	—	+ Add to CRM
AZ AZ Venture Capital Inc. JGSRJPJN5 people · Follows rounds	88🔒	Phoenix	US	Pre-Seed–Series B	—	+ Add to CRM
LE Lewis & Clark AgriFood DLLPTHLE5 people · Leads rounds	88🔒	St. Louis	US	Series A–Late Stage	$2M – $10M	+ Add to CRM
PA Pathway Bioventures DJMBMMJS5 people	88🔒	Chicago	US	Pre-Seed–Series A	—	+ Add to CRM
TO TO VC AMJPCC5 people · Follows rounds	88🔒	New York	US	Seed–Series B	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Seed–Late Stage	$5M – $15M	+ Add to CRM

Berkeley Catalyst

BerkeleySeed–Series A

DLLSTH3 people

7G BioVentures

Burlingame

VXSWPDRD5 people

Kendall Capital Partners

BostonSeed–Growth

DZJBDRGM7 people

Torrey Pines Investment

San DiegoSeed–Series A

NSCRERMP7 people

Corner Ventures

New YorkSeed–Late Stage

JPMTDKDK12 people

Deviation Capital

New YorkSeed–Growth

CBDPJGTM6 people

ETCapital

CambridgePre-Seed–Series A$100K – $952.5K

MRJGDG3 people

Jumpstart Nova

NashvilleSeed–Series A$250K – $4M

MWKCVG3 people

Militia Hill Ventures

PhiladelphiaSeed–Series A

JHBJLDS9 people

Ono Venture Investment, Inc.

South San FranciscoSeed–Series B

SMDNHTKT6 people

Claremont Creek Ventures

OaklandSeed–Late Stage$500K – $3M

NGRHBWGO5 people

Hourglass Venture Partners

San Francisco

RELGSRS8 people

Sugati Ventures

San RamonSeed–Series A

RDEGMCEH8 people

7thirty

BoulderSeed–Series B$100K – $1M

JJMT2 people

BlueStone Venture Partners

TucsonSeed–Series B$250K – $1M

MATNCBAM4 people

Louisiana Funds

Baton RougePre-Seed–Series A

RBJLLML4 people

Actuate Ventures

SeattlePre-Seed–Seed

AWCLJOJW6 people

SVG Ventures

Silicon ValleyPre-Seed–Series A

HHJHGYJC9 people

Aditum Bio

OaklandSeries A–Series B

JGJJCKIZ8 people

AZ Venture Capital Inc.

PhoenixPre-Seed–Series B

JGSRJPJN5 people

Lewis & Clark AgriFood

St. LouisSeries A–Late Stage$2M – $10M

DLLPTHLE5 people

Pathway Bioventures

ChicagoPre-Seed–Series A

DJMBMMJS5 people

TO VC

New YorkSeed–Series B

AMJPCC5 people

Kern Capital, LLC

LarkspurSeed–Late Stage$5M – $15M

JK1 person

Data sourced from public filings and firms' own websites — see our methodology.